Angiotensin II type 2 receptor signaling affects dopamine levels in the brain and prevents binge eating disorder
Conclusions:
Our study suggests that AT2 receptor stimulation may be a new therapeutic approach to improve eating disorder associated with dopamine resistance.
Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - Category: Biomedical Science Authors: Nakaoka, H., Mogi, M., Kan-no, H., Tsukuda, K., Ohshima, K., Wang, X.-L., Chisaka, T., Bai, H.-Y., Shan, B.-S., Kukida, M., Iwanami, J., Horiuchi, M. Tags: Original Articles Source Type: research
More News: Binge Eating Disorder | Biomedical Science | Brain | Diabetes | Diabetes Type 2 | Endocrinology | Neurology | Study